Links with collaborating institutions are maintained in the current research undertakings and have extended to the Health Policy Planning Research and Infectious Disease Cluster Offices of the Department of Health, Manila; the Community Health Development Offices of CAR, Region 4, CARAGA and Region 11; the Mindanao Health Development Office and the Philippines’ Roll Back Malaria initiatives (in partnership with WHO-WPRO, Infectious Disease Surveillance and Control Project-USAID and the RP-DOH/US- NAMRU Malaria Project).

Though the research program activities, significant contributions were made to the local malaria control which include the training of trainers in malaria microscopy and clinical management of the disease, and the development of training manuals and health education materials. Translating research and project findings into malaria control strategies and health policies is a high priority.

On-going researches are as follows: (1) Implementation and Evaluation of A Self-Sustaining Community-based Malaria Control Program in Hyperendemic Areas of Agusan del Sur (AusAID); (2) A Community-based Malaria Control Program in El Nido, Palawan (El Nido Foundation and Philippine Rural Reconstruction Movement); (3) Characterization of Philippine Malaria Vectors Using DNA Markers (Wellcome Trust); (4) Community-based studies of CQ + SP versus Artemether-lumefantrine (Coartem ®) and CQ + SP versus SP for uncomplicated P. falciparum malaria in Mindanao Island, the Philippines (RBM/WHO/WPRO); (5) Devolution and Health Sector Reform Agenda: Implications for Community-based Malaria Control Program in the Philippines [UNDP/WORLD BANK/WHO Special Program for Research and Training in Tropical Diseases (TDR)]; (6) Drug Resistance Patterns of P. falciparum and P. vivax in Selected Areas in the Philippines (Essential National Health Research –Dept. of Health, Philippines); (7) Establishment of Nationwide Network for the Determination and Mapping out of Insecticide Susceptibility/ Resistance of Malaria Vectors in the Philippines (Roll Back Malaria/ WHOWPRO); and (8) Evaluation of Serological Test Kits for Malaria, SD Malaria Kit ® (Standard Diagnostics Korea) and (9) Phase II Dose-Ranging Study of Azithromycin-Fansidar Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in the Philippines (US-NIH, Pfizer, US)